ArticlePharmaceuticals (Basel, Switzerland)2025

Impact of Fixed-Dose Combination Versus Single-Component Therapy for Benign Prostatic Hyperplasia-Related Urinary Symptoms on Persistence, Adherence, and Satisfaction in a Real-Life Setting.

Mateusz Małkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.